Related Experiment Video
Updated: Jun 13, 2026
04:33
Primary Culture of Rat Adrenocortical Cells and Assays of Steroidogenic Functions
Published on: March 12, 2019
Nongenomic steroid action: Inhibiting effects on cell-to-cell communication between rat ventricular myocytes
F Verrecchia1, D Sarrouilhe, J C Hervé
1Physiologie Cellulaire, UMR CNRS 6558.
Experimental and Clinical Cardiology
|April 30, 2010
Summary
Steroid esters like 17beta-estradiol and testosterone rapidly block cell communication in heart cells. This rapid, nongenomic effect suggests steroids impact membrane proteins and cell junctions.
Area of Science:
- Cardiovascular Science
- Cell Biology
- Endocrinology
Background:
- Steroids can rapidly affect cell membranes independently of gene pathways.
- Steroids modulate membrane proteins, including ion channels.
Purpose of the Study:
- To investigate the effects of various steroids on intercellular communication via gap junctions in rat cardiac myocytes.
- To compare the rapid membrane effects of different steroid classes on junctional permeability and conductance.
Main Methods:
- Assessed junctional permeability using fluorescent dye and electrical conductance in newborn rat cardiac myocytes.
- Applied various steroid esters, including 17beta-estradiol and testosterone, at 25 muM.
- Tested effects of different steroid families (pregnane, sterol, bile acid, vitamin D3) and their structural features.
Main Results:
- Esterified 17beta-estradiol, testosterone, and other androgens rapidly abolished cell-to-cell communication.
- Longer chain steroids, sterols, bile acids, and vitamin D3 did not lower junctional permeability.
- Esterification was crucial for activity; molecular shape was less important than size and lipo-solubility.
Conclusions:
- Steroid esters rapidly disrupt gap junction communication through a nongenomic mechanism.
- The rapid, reversible uncoupling is likely related to steroid size and lipo-solubility, affecting the lipid bilayer.
- These findings highlight a non-classical, rapid signaling pathway for certain steroids in cardiac cells.
Related Concept Videos
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:18Antihypertensive Drugs: Action of Calcium Channel Blockers
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...